一般向け、基礎疾患の人と並行　ワクチン職場接種にモデルナ製検討―田村厚労相

　田村憲久厚生労働相は３０日のＮＨＫの番組で、６５歳以上の高齢者に続く新型コロナウイルスのワクチン接種について、基礎疾患がある人と一般向けを並行して実施できる体制を整えるよう各自治体に求めた。職場で接種する場合は、米モデルナ製ワクチンを提供したいとの考えを示した。
　田村氏は６４歳以下の接種に関し「基礎疾患を持つ方は自己申告によるため、どれくらいいるか分からない。いつ終わるか分からない話になるから、一般の方々も一緒に動いていくと考えてもらっていい」と述べた。
　また、モデルナ製ワクチンについて、現在高齢者向け接種が進む米ファイザー製と保管方法などが異なる点を挙げ、「職域で打っていただくことも検討中だ」と強調した。（2021/05/30-15:32）

Japanese health minister Norihisa Tamura in a television program on Sunday asked local governments to prepare to allow younger people without pre-existing conditions to get novel coronavirus vaccines simultaneously with those having such issues.
   Referring to people aged 64 or under, Tamura said, "We don't know how many of them have underlying issues because it is not mandatory for them to declare their conditions (when receiving coronavirus vaccines)."
   It remains to be seen when vaccinations of people having pre-existing conditions will be completed, so those without underlying health issues should be allowed to get jabs simultaneously with them, he said.
   Tamura also suggested that the government is considering offering a vaccine developed by U.S. biotechnology company Moderna Inc., which was approved in Japan on May 21, for inoculations to be carried out at workplaces, citing differences between the Moderna product and a vaccine from U.S. pharmaceutical giant Pfizer Inc. in terms of storage methods and other aspects.
   Japan's novel coronavirus inoculation program now mainly covers people aged 65 or over, the second priority group, after the first priority group of medical workers, chiefly using the vaccine developed by Pfizer.